APP and Alzheimer disease: Sulforaphane administration ameliorates cognitive impairment and reduces Aβ accumulation in the brains of 5xFAD mice with five human mutations in APP and PS1 and 3xTg-AD lines with three human mutations in APP, PS1, and TAU [90].